This presentation will focus on the pharmacodynamic and pharmacokinetic principles in neonatal populations and the implications for medication selection and monitoring. We will discuss parameters related to these principles and how pharmacotherapeutic regimens are determined using them. Absorption, distribution, metabolism, and elimination of medications and the clinical impact of neonatal patient characteristics and medication properties on pharmacotherapeutic decisions will also be presented. We will also contrast medications and why medications may be preferred for some neonatal disease states due to medication characteristics. The information provided will act as a foundation for pharmacotherapeutic recommendations based on patient and mediation specific properties for neonatal disease states.
Learning Objectives:
Objective 1: Determine the impact of pharmacodynamic and pharmacokinetic principles in medication selection for selected disease states
Objective 2: Contrast medication dosing strategies based on neonatal pharmacodynamics and pharmacokinetic parameters
Objective 3: Develop a process for monitoring pharmacotherapeutic regimens based on normal and changing pharmacodynamic and pharmacokinetic patient characteristics
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
